Enzyme-inhibitor-complexes in thrombosis test

Details Enzyme-inhibitor-complexes in thrombosis test Enzyme-inhibitor-complexes in thrombosis test

G - Physics

01

N

167/41, 167/44

G01N 23/00 (2006.01) C12Q 1/56 (2006.01)

Patent

CA 1095406

ABSTRACT OF THE DISCLOSURE A thrombosis test is based on the presence of specific, newly-found, enzyme-inhibitor complexes (such as plasmin- antiplasim, plasmin-.alpha.2- macroglobulin, thrombin-antithrombin-III) in blood samples having an activated blood coagulation and/or fibrinolytic system. The test is immunochemical and comprises e.g. an agglutination or agglutination-inhibition test. The preparation and purification of required reagents such as antiserums against the enzyme-inhibitor complexes, a blood-cell reagent and a latex reagent, are also disclosed.

261260

Affiliated with

Also associated with

Rating

Enzyme-inhibitor-complexes in thrombosis test does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enzyme-inhibitor-complexes in thrombosis test, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzyme-inhibitor-complexes in thrombosis test will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-999223